SUBSCRIBE
SUBSCRIBE
News   Business

Emergent BioSolutions 4Q Profit Plunges

March 6, 2009 | 
1 min read

Emergent BioSolutions Inc. said Thursday its fourth-quarter profit plunged on a delay in deliveries of its anthrax vaccine BioThrax.

Earnings
MORE ON THIS TOPIC
Pictured: Pfizer office at its South San Francisco
Earnings
Pfizer Exceeds Wall Street’s Q3 Expectations Amid Activist Investor Pressure
October 29, 2024
 · 
2 min read
 · 
Greg Slabodkin
External view of Novartis' office in Canada
Earnings
Novartis Gets Q3 Beat on Strong Cosentyx Sales, But Pluvicto Disappoints
October 29, 2024
 · 
2 min read
 · 
Tristan Manalac
U.S. and Chinese flags in concrete, broken in the middle
Earnings
WuXi AppTec Remains Resilient Amid Threat from BIOSECURE Act, Continues to Attract New Clients
October 29, 2024
 · 
2 min read
 · 
Tristan Manalac
Psychological concept. Chaotic thought process
Business
AbbVie Doubles Down on Alzheimer’s With $1.4B Aliada Buy
October 28, 2024
 · 
2 min read
 · 
Heather McKenzie